nsulin is a life-saving medication for people with type 1 diabetes, but traditional insulin replacement therapy is based on multiple daily subcutaneous injections or continuous subcutaneous pump-regulated infusion. Nonphysiologic delivery of subcutaneous insulin implies a rapid and sustained increase in systemic insulin levels due to the loss of concentration gradient between portal and systemic circulations. In fact, the liver degrades about half of the endogenous insulin secreted by the pancreas into the venous portal system. The reverse insulin distribution has short- and long-term effects on glucose metabolism. Thus, researchers have explored less-invasive administration routes based on innovative pharmaceutical formulations, which preserve hormone stability and ensure the therapeutic effectiveness. This review examines some of the recent proposals from clinical and material chemistry point of view, giving particular attention to patients' (and diabetologists') ideal requirements that organic chemistry could meet.

Matteucci, E., Giampietro, O., Covolan, V., Giustarini, D., Fanti, P., Rossi, R. (2015). Insulin administration: Present strategies and future directions for a noninvasive (possibly more physiological) delivery. DRUG DESIGN, DEVELOPMENT AND THERAPY, 9, 3109-3118 [10.2147/DDDT.S79322].

Insulin administration: Present strategies and future directions for a noninvasive (possibly more physiological) delivery

GIUSTARINI, DANIELA;ROSSI, RANIERI
2015-01-01

Abstract

nsulin is a life-saving medication for people with type 1 diabetes, but traditional insulin replacement therapy is based on multiple daily subcutaneous injections or continuous subcutaneous pump-regulated infusion. Nonphysiologic delivery of subcutaneous insulin implies a rapid and sustained increase in systemic insulin levels due to the loss of concentration gradient between portal and systemic circulations. In fact, the liver degrades about half of the endogenous insulin secreted by the pancreas into the venous portal system. The reverse insulin distribution has short- and long-term effects on glucose metabolism. Thus, researchers have explored less-invasive administration routes based on innovative pharmaceutical formulations, which preserve hormone stability and ensure the therapeutic effectiveness. This review examines some of the recent proposals from clinical and material chemistry point of view, giving particular attention to patients' (and diabetologists') ideal requirements that organic chemistry could meet.
2015
Matteucci, E., Giampietro, O., Covolan, V., Giustarini, D., Fanti, P., Rossi, R. (2015). Insulin administration: Present strategies and future directions for a noninvasive (possibly more physiological) delivery. DRUG DESIGN, DEVELOPMENT AND THERAPY, 9, 3109-3118 [10.2147/DDDT.S79322].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/990210
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo